Skip to content

Comparison of continuous paravertebral blockade (PVB) and continuous thoracic epidural analgesia (TEA) for analgesia following open renal surgery

Comparison of continuous paravertebral blockade (PVB) and continuous thoracic epidural analgesia (TEA) for analgesia following open renal surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-004998-17-IE
Enrollment
Unknown
Registered
2008-08-19
Start date
2008-10-17
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study will involve the administration of levobupivacaine 0.25% and 0.125%, a local anaesthetic agent licensed for this purpose, into the epidural and paravertebral space, to provide postoperative analgesia for adults having open renal surgery. We aim to compare the analgesic efficacy of paravertebral and epidural blockage, for post operative pain in the first 24 post operative hours. MedDRA version: 9.1 Level: LLT Classification code 10054711 Term: Postoperative pain

Interventions

Trade Name: Chirocaine Product Name: Levobupivacaine Pharmaceutical Form: Solution for infusion Trade Name: Chirocaine Product Name: Levobupivacaine Pharmaceutical Form: Solution for infusion Trade

Sponsors

Department of Anaesethesia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults 18-80 years Presenting for elective open renal surgery ASA 1 to 3 Written informed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patient refusal Contraindication to neuraxial blockade Local infection at site of insertion Allergy to levobupivacaine, fentanyl, paracetamol or morphine. Sepsis Severe kyphoscoliosis Previous thoracic vertebral surgery Systemic anticoagulation or coagulopathy Uncontrolled hypertension Uncontrolled Diabetes Mellitus Severe liver or cardiac dysfunction Inability to comprehend pain scoring system or perform spirometry

Design outcomes

Primary

MeasureTime frame
Primary end point(s): Pain assessment in the first 24 hours, (VAS and categorical pain scores) Morphine requirement in first 24 hours;Main Objective: We aim to compare the analgesic efficacy of paravertebral and epidural blockage, for post operative pain in the first 24 post operative hours, following open renal surgery. 1. Severity of Postoperative Pain, [VAS and Categorical pain Scales] 2. Total opiate usage in the first 48 hours after surgery;Secondary Objective: Poorly controlled analgesia is associated with prolongation of hospital stay, and increased morbidity. The use of epidural and paravertebral nerve blocks is a well-established approach to postoperative analgesia. We plan to show that both epidural and paravertebral analgesia will provide very satisfactory analgesia post operatively. The use of epidural is associated with more blood pressure instability, higher fluid requirement to maintain blood pressure and urine production, and also leg weakness delaying mobilization. We plan to show a statistically significant difference in these side effects. 1Cardiovascular hemodynamics 2Respiratory function 3Fluid requirement in first 24 hours 4Hourly urine output in first 24 hours 5Sedation 6Postoperative nausea, vomiting and itch 7Patient Satisfaction

Countries

Ireland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026